Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR)

NCT00210431 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00210431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
October 31, 2004
Completion date
June 30, 2006
Enrollment
783 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

blepharospasm, cerebral palsy, cerebrovascular accident, cervical dystonia, equinus deformity, facial hyperdynamic lines, hemifacial spasm, muscle spasticity, spasmodic torticollis